Dialister invisus is predominantly found in the oral cavities of individuals suffering from endodontic infections, affecting the dental pulp or root canal. This bacterium has a high prevalence rate of 68.3% in cases of irreversible pulpitis, a severe type of endodontic infection that leads to inflammation and death of the dental pulp.
The discovery of Dialister invisus dates back to 2003, when J. Downes first identified it. The bacterium was isolated through 16S rRNA sequencing from the root canals of patients suffering from chronic endodontic lesions. There have been no reported instances of outbreaks or epidemics caused by Dialister invisus in the findings.
Despite the lack of reported outbreaks, Dialister invisus is recognized as a significant human pathogen capable of causing severe oral health issues. Given its potential to cause health problems, it is crucial to keep track of its prevalence and virulence across various populations and environments.
Classification and Structure:
Kingdom: Bacteria
Phylum: Firmicutes
Class: Clostridia
Order: Clostridiales
Family: Acidaminococcaceae
Genus:Dialister
Species:D. invisus
Dialister invisus is a tiny coccobacillus, a term that describes its unique shape that falls between a sphere (coccus) and a rod (bacillus). Although the precise measurements are not specified, coccobacilli are normally less than 1 micrometer in diameter and length.
This bacterium can exist in various formations – individually, in pairs, in chains, or small clusters.
Dialister invisus is non-motile, indicating it lacks any appendages that enable movement. It is classified as gram-negative due to its thin peptidoglycan layer enveloped by an outer membrane. This bacterium is an obligate anaerobe, which means it cannot survive in oxygen-rich environments.
Dialister invisus is asaccharolytic, implying it does not utilize sugars as an energy source. It generates acetate and propionate as the end products of its metabolism.The bacterium possesses a single chromosome with a genome size of 1.9 Mb. No plasmids have been detected from the partial genome construction.
Dialister invisus exhibits several distinctive characteristics that influence its role within the oral microbiome. This bacterium is known for its ability to produce acetate and propionate from amino acids. This metabolic process can lead to a decrease in pH, resulting in an acidic environment. Such acidity can have implications for the oral ecosystem, affecting microbial interactions and health.
Notably, Dialister invisus expresses antibiotic resistance genes, including ermF, tetQ, and tetW, which confer resistance to macrolides, tetracyclines, and other antibiotics. This resistance highlights the adaptability of this bacterium and underscores the importance of prudent antibiotic usage in clinical settings.
Additionally, D. invisus can form biofilms in conjunction with other oral bacteria like Porphyromonas gingivalis and Treponema denticola. These biofilms enhance adherence and persistence within the oral cavity, playing a role in oral health and disease progression. Moreover, Dialister invisus secretes proteases and hyaluronidases, enzymes that can degrade the extracellular matrix and host tissues, facilitating its invasion and dissemination within the host.
The various strains of Dialister invisus, including CCUG 47026T, CIP108215T, E7.25T, DSM 15470T, and JCM 17566T, collectively exemplify the diversity within this bacterial species and its intricate adaptations and interactions in the oral environment.
Dialister invisus, an asaccharolytic and obligate anaerobe bacterium, can exist symptomatically and asymptomatically within the human body. Its presence and impact largely depend on its location within the body. For instance, when present in the intestinal tract, it does not appear to cause disease. However, when detected, it was associated in urinary tract infections.
The oral cavity is often associated with various oral diseases, such as caries, halitosis, periocoronitis, apical & marginal periodontitis, and endodontic infections. Specifically, its presence in root canals has been shown to the form apical periodontitis lesions.
The bacterium prefers third molar sites in juvenile patients, which can harbor these pathogens even in healthy mouths. This is evidenced by the fact that D. invisus is found in greater incidence in erupted third molars than in plaque from other teeth. Interestingly, the microbial variations in the oral cavity that signal the onset of periodontitis often first appear in the third molar region of teenagers.
Beyond the oral cavity, D. invisus isolated from the female reproductive system has been implicated in bacterial salpingitis & vaginosis. As research into D. invisus continues, it is emerging as a potential endodontic pathogen. However, this species’ actual prevalence and locations may be significantly underrepresented due to the difficulty in isolating and culturing it. It may be present in other body areas that have not yet been discovered.
Studies into the antibiotic resistance of D. invisus have shown that all Dialister strains are resistant to vancomycin but sensitive to colistin and kanamycin. As the association of this bacterium becomes more pronounced with oral disease, the importance of monitoring the evolution of its antibiotic resistance increases. It is crucial in managing its pathogenesis and developing effective treatment strategies.
Understanding the human host’s defense mechanisms against Dialister invisus is essential, especially in inflammatory bowel disease (IBD) and gut dysbiosis.
Mucosal Barrier Integrity: The first line of defense against Dialister invisus and other gut bacteria is the intestinal mucosal barrier. This barrier comprises a layer of mucus and epithelial cells that physically separate the bacteria from the underlying tissues. A healthy mucosal barrier helps prevent the invasion of bacteria, including Dialister invisus, into the gut lining.
Beneficial Microbiota: One of the host’s natural defenses is a diverse and balanced gut microbiota. When the gut is populated with a wide variety of beneficial bacteria, they can compete with potential pathogens like Dialister invisus for resources and space, limiting their growth and impact.
Immune System Surveillance: The host’s immune system detects and acts against invasive bacteria like Dialister invisus. Immune cells in the gut, such as dendritic cells and macrophages, are responsible for monitoring the gut environment and initiating immune responses when necessary.
Secretory Immunoglobulin A (sIgA): sIgA is an antibody found in the gut’s mucosal lining. It plays a crucial role in immune defense against bacteria, including Dialister invisus, by binding them and preventing their adhesion to the gut epithelium. This action limits the ability of the bacteria to colonize and cause harm.
Inflammatory Responses: During an increased load of Dialister invisus, the host’s immune system can mount an inflammatory response. This response includes the release of pro-inflammatory cytokines and launching immune cells to the infection site, helping to contain and eliminate the bacteria.
Microbiota-Metabolite Interactions: Butyrate and other short-chain fatty acids (SCFAs) produced by the gut microbiota play a critical role in maintaining gut health. Butyrate, in particular, has anti-inflammatory properties and can trigger the development of regulatory T cells (Tregs), which help in immune regulation and maintaining gut homeostasis. Dialister invisus and other bacteria contributing to SCFA production indirectly support the host’s immune system.
Adaptive Immunity: Over time, the host’s adaptive immune system can develop specific responses to Dialister invisus if it becomes a recurrent threat. This involves the production of antibodies and memory immune cells that can recognize and respond more effectively to future exposures.
Dialister invisus is predominantly found in the oral cavity of individuals suffering from endodontic infections. The term ‘endodontic’ pertains to the dental pulp, which is the central part of the tooth composed of living connective tissue and cells. While endodontic infections often occur in the root canal, this is not always true.
In humans, the presence of Dialister invisus can lead to several clinical symptoms, including:
Periodontitis: It is an infection and inflammation of the gums & the structures that support the teeth.
Caries: This condition involves the decay and damage of the tooth’s enamel and dentin, which can result in cavities.
Halitosis: Commonly called bad breath, this condition is caused by the accumulation of bacteria and the breakdown of organic compounds in the mouth.
Apical Periodontitis: This is an infection and inflammation of the tissues surrounding the root tip of a tooth. It often occurs as a result of an untreated endodontic infection.
Dialister invisus has implications beyond the oral cavity, with links to systemic diseases such as Crohn’s disease, spondyloarthritis, systemic lupus erythematosus, and autism spectrum disorders. These diseases are intricately tied to alterations in the gut microbiome, which is influenced by D. invisus infection.
Notably, the abundance of D. invisus has been found to vary in patients with different conditions; it is reduced in individuals with Crohn’s disease, while it exhibits a positive association with spondyloarthritis.
Diagnosing Dialister infections typically requires a combination of culture-based & culture-independent methods due to the bacterium’s unique characteristics. It isn’t easy to grow in the laboratory, so culture-independent methods are usually preferred for diagnosis. Here are some diagnostic approaches:
Culture Test:Dialister invisus can be cultured using selective media, such as Columbia blood agar. This medium contains sheep blood, hemin, vitamin K and supports the growth. However, culturing Dialister invisus necessitates specific conditions, primarily anaerobic environments, and extended incubation periods (usually around 7 days at 37°C). Colonies of D. invisus on Columbia blood agar are typically small, circular, and transparent.
Gram Staining: A fundamental technique in microbiology can confirm the identity of D. invisus after culturing or molecular detection methods. This staining technique differentiates bacteria based on the structure of their cell wall. D. invisus possesses a thin peptidoglycan layer encircled by an outer membrane, resulting in a pink or red coloration in gram staining.
Molecular Techniques – 16S rRNA Sequencing: Culture-independent methods are often preferred for diagnosing D. invisus infections since it can be challenging to grow this bacterium in the laboratory. One such method is 16S rRNA sequencing, a molecular technique that identifies bacterial species based on their genetic signatures. This method has been used effectively to detect and isolate D. invisus from various clinical samples.
Fluorescence In Situ Hybridization (FISH): FISH employs fluorescent probes to target and visualize Dialister invisus DNA or RNA in clinical samples.
Checkerboard DNA-DNA hybridization: It is a versatile method in microbiological research, particularly for assessing the presence and quantity of Dialister invisus in complex samples such as subgingival plaque. This technique utilizes DNA probes designed to complement distinct regions of DNA from various bacterial species.
By hybridizing these probes with DNA extracted from a sample, researchers can pinpoint the presence and quantify the abundance of Dialister invisus and other periodontal pathogens. This approach has proven valuable in evaluating the impact of treatments like scaling and root planing on the subgingival microbiota.
Maintaining good oral hygiene is mandatory in preventing oral infections, including those potentially related to bacteria like Dialister invisus. This involves regular brushing and flossing to remove plaque and debris, using mouthwash to kill harmful bacteria, and scheduling routine dental check-ups to catch and address any oral health issues early.
Diet is crucial in oral health maintenance. Avoiding or limiting consuming foods rich in sugars, starches, and acidic substances can help prevent bacterial growth and tooth decay.
If there are signs of infection or inflammation in the teeth or gums, following prescribed antibiotics as directed by a healthcare professional is essential. Timely treatment is critical in preventing the spread of infection.
Dialister invisus is predominantly found in the oral cavities of individuals suffering from endodontic infections, affecting the dental pulp or root canal. This bacterium has a high prevalence rate of 68.3% in cases of irreversible pulpitis, a severe type of endodontic infection that leads to inflammation and death of the dental pulp.
The discovery of Dialister invisus dates back to 2003, when J. Downes first identified it. The bacterium was isolated through 16S rRNA sequencing from the root canals of patients suffering from chronic endodontic lesions. There have been no reported instances of outbreaks or epidemics caused by Dialister invisus in the findings.
Despite the lack of reported outbreaks, Dialister invisus is recognized as a significant human pathogen capable of causing severe oral health issues. Given its potential to cause health problems, it is crucial to keep track of its prevalence and virulence across various populations and environments.
Classification and Structure:
Kingdom: Bacteria
Phylum: Firmicutes
Class: Clostridia
Order: Clostridiales
Family: Acidaminococcaceae
Genus:Dialister
Species:D. invisus
Dialister invisus is a tiny coccobacillus, a term that describes its unique shape that falls between a sphere (coccus) and a rod (bacillus). Although the precise measurements are not specified, coccobacilli are normally less than 1 micrometer in diameter and length.
This bacterium can exist in various formations – individually, in pairs, in chains, or small clusters.
Dialister invisus is non-motile, indicating it lacks any appendages that enable movement. It is classified as gram-negative due to its thin peptidoglycan layer enveloped by an outer membrane. This bacterium is an obligate anaerobe, which means it cannot survive in oxygen-rich environments.
Dialister invisus is asaccharolytic, implying it does not utilize sugars as an energy source. It generates acetate and propionate as the end products of its metabolism.The bacterium possesses a single chromosome with a genome size of 1.9 Mb. No plasmids have been detected from the partial genome construction.
Dialister invisus exhibits several distinctive characteristics that influence its role within the oral microbiome. This bacterium is known for its ability to produce acetate and propionate from amino acids. This metabolic process can lead to a decrease in pH, resulting in an acidic environment. Such acidity can have implications for the oral ecosystem, affecting microbial interactions and health.
Notably, Dialister invisus expresses antibiotic resistance genes, including ermF, tetQ, and tetW, which confer resistance to macrolides, tetracyclines, and other antibiotics. This resistance highlights the adaptability of this bacterium and underscores the importance of prudent antibiotic usage in clinical settings.
Additionally, D. invisus can form biofilms in conjunction with other oral bacteria like Porphyromonas gingivalis and Treponema denticola. These biofilms enhance adherence and persistence within the oral cavity, playing a role in oral health and disease progression. Moreover, Dialister invisus secretes proteases and hyaluronidases, enzymes that can degrade the extracellular matrix and host tissues, facilitating its invasion and dissemination within the host.
The various strains of Dialister invisus, including CCUG 47026T, CIP108215T, E7.25T, DSM 15470T, and JCM 17566T, collectively exemplify the diversity within this bacterial species and its intricate adaptations and interactions in the oral environment.
Dialister invisus, an asaccharolytic and obligate anaerobe bacterium, can exist symptomatically and asymptomatically within the human body. Its presence and impact largely depend on its location within the body. For instance, when present in the intestinal tract, it does not appear to cause disease. However, when detected, it was associated in urinary tract infections.
The oral cavity is often associated with various oral diseases, such as caries, halitosis, periocoronitis, apical & marginal periodontitis, and endodontic infections. Specifically, its presence in root canals has been shown to the form apical periodontitis lesions.
The bacterium prefers third molar sites in juvenile patients, which can harbor these pathogens even in healthy mouths. This is evidenced by the fact that D. invisus is found in greater incidence in erupted third molars than in plaque from other teeth. Interestingly, the microbial variations in the oral cavity that signal the onset of periodontitis often first appear in the third molar region of teenagers.
Beyond the oral cavity, D. invisus isolated from the female reproductive system has been implicated in bacterial salpingitis & vaginosis. As research into D. invisus continues, it is emerging as a potential endodontic pathogen. However, this species’ actual prevalence and locations may be significantly underrepresented due to the difficulty in isolating and culturing it. It may be present in other body areas that have not yet been discovered.
Studies into the antibiotic resistance of D. invisus have shown that all Dialister strains are resistant to vancomycin but sensitive to colistin and kanamycin. As the association of this bacterium becomes more pronounced with oral disease, the importance of monitoring the evolution of its antibiotic resistance increases. It is crucial in managing its pathogenesis and developing effective treatment strategies.
Understanding the human host’s defense mechanisms against Dialister invisus is essential, especially in inflammatory bowel disease (IBD) and gut dysbiosis.
Mucosal Barrier Integrity: The first line of defense against Dialister invisus and other gut bacteria is the intestinal mucosal barrier. This barrier comprises a layer of mucus and epithelial cells that physically separate the bacteria from the underlying tissues. A healthy mucosal barrier helps prevent the invasion of bacteria, including Dialister invisus, into the gut lining.
Beneficial Microbiota: One of the host’s natural defenses is a diverse and balanced gut microbiota. When the gut is populated with a wide variety of beneficial bacteria, they can compete with potential pathogens like Dialister invisus for resources and space, limiting their growth and impact.
Immune System Surveillance: The host’s immune system detects and acts against invasive bacteria like Dialister invisus. Immune cells in the gut, such as dendritic cells and macrophages, are responsible for monitoring the gut environment and initiating immune responses when necessary.
Secretory Immunoglobulin A (sIgA): sIgA is an antibody found in the gut’s mucosal lining. It plays a crucial role in immune defense against bacteria, including Dialister invisus, by binding them and preventing their adhesion to the gut epithelium. This action limits the ability of the bacteria to colonize and cause harm.
Inflammatory Responses: During an increased load of Dialister invisus, the host’s immune system can mount an inflammatory response. This response includes the release of pro-inflammatory cytokines and launching immune cells to the infection site, helping to contain and eliminate the bacteria.
Microbiota-Metabolite Interactions: Butyrate and other short-chain fatty acids (SCFAs) produced by the gut microbiota play a critical role in maintaining gut health. Butyrate, in particular, has anti-inflammatory properties and can trigger the development of regulatory T cells (Tregs), which help in immune regulation and maintaining gut homeostasis. Dialister invisus and other bacteria contributing to SCFA production indirectly support the host’s immune system.
Adaptive Immunity: Over time, the host’s adaptive immune system can develop specific responses to Dialister invisus if it becomes a recurrent threat. This involves the production of antibodies and memory immune cells that can recognize and respond more effectively to future exposures.
Dialister invisus is predominantly found in the oral cavity of individuals suffering from endodontic infections. The term ‘endodontic’ pertains to the dental pulp, which is the central part of the tooth composed of living connective tissue and cells. While endodontic infections often occur in the root canal, this is not always true.
In humans, the presence of Dialister invisus can lead to several clinical symptoms, including:
Periodontitis: It is an infection and inflammation of the gums & the structures that support the teeth.
Caries: This condition involves the decay and damage of the tooth’s enamel and dentin, which can result in cavities.
Halitosis: Commonly called bad breath, this condition is caused by the accumulation of bacteria and the breakdown of organic compounds in the mouth.
Apical Periodontitis: This is an infection and inflammation of the tissues surrounding the root tip of a tooth. It often occurs as a result of an untreated endodontic infection.
Dialister invisus has implications beyond the oral cavity, with links to systemic diseases such as Crohn’s disease, spondyloarthritis, systemic lupus erythematosus, and autism spectrum disorders. These diseases are intricately tied to alterations in the gut microbiome, which is influenced by D. invisus infection.
Notably, the abundance of D. invisus has been found to vary in patients with different conditions; it is reduced in individuals with Crohn’s disease, while it exhibits a positive association with spondyloarthritis.
Diagnosing Dialister infections typically requires a combination of culture-based & culture-independent methods due to the bacterium’s unique characteristics. It isn’t easy to grow in the laboratory, so culture-independent methods are usually preferred for diagnosis. Here are some diagnostic approaches:
Culture Test:Dialister invisus can be cultured using selective media, such as Columbia blood agar. This medium contains sheep blood, hemin, vitamin K and supports the growth. However, culturing Dialister invisus necessitates specific conditions, primarily anaerobic environments, and extended incubation periods (usually around 7 days at 37°C). Colonies of D. invisus on Columbia blood agar are typically small, circular, and transparent.
Gram Staining: A fundamental technique in microbiology can confirm the identity of D. invisus after culturing or molecular detection methods. This staining technique differentiates bacteria based on the structure of their cell wall. D. invisus possesses a thin peptidoglycan layer encircled by an outer membrane, resulting in a pink or red coloration in gram staining.
Molecular Techniques – 16S rRNA Sequencing: Culture-independent methods are often preferred for diagnosing D. invisus infections since it can be challenging to grow this bacterium in the laboratory. One such method is 16S rRNA sequencing, a molecular technique that identifies bacterial species based on their genetic signatures. This method has been used effectively to detect and isolate D. invisus from various clinical samples.
Fluorescence In Situ Hybridization (FISH): FISH employs fluorescent probes to target and visualize Dialister invisus DNA or RNA in clinical samples.
Checkerboard DNA-DNA hybridization: It is a versatile method in microbiological research, particularly for assessing the presence and quantity of Dialister invisus in complex samples such as subgingival plaque. This technique utilizes DNA probes designed to complement distinct regions of DNA from various bacterial species.
By hybridizing these probes with DNA extracted from a sample, researchers can pinpoint the presence and quantify the abundance of Dialister invisus and other periodontal pathogens. This approach has proven valuable in evaluating the impact of treatments like scaling and root planing on the subgingival microbiota.
Maintaining good oral hygiene is mandatory in preventing oral infections, including those potentially related to bacteria like Dialister invisus. This involves regular brushing and flossing to remove plaque and debris, using mouthwash to kill harmful bacteria, and scheduling routine dental check-ups to catch and address any oral health issues early.
Diet is crucial in oral health maintenance. Avoiding or limiting consuming foods rich in sugars, starches, and acidic substances can help prevent bacterial growth and tooth decay.
If there are signs of infection or inflammation in the teeth or gums, following prescribed antibiotics as directed by a healthcare professional is essential. Timely treatment is critical in preventing the spread of infection.
Dialister invisus is predominantly found in the oral cavities of individuals suffering from endodontic infections, affecting the dental pulp or root canal. This bacterium has a high prevalence rate of 68.3% in cases of irreversible pulpitis, a severe type of endodontic infection that leads to inflammation and death of the dental pulp.
The discovery of Dialister invisus dates back to 2003, when J. Downes first identified it. The bacterium was isolated through 16S rRNA sequencing from the root canals of patients suffering from chronic endodontic lesions. There have been no reported instances of outbreaks or epidemics caused by Dialister invisus in the findings.
Despite the lack of reported outbreaks, Dialister invisus is recognized as a significant human pathogen capable of causing severe oral health issues. Given its potential to cause health problems, it is crucial to keep track of its prevalence and virulence across various populations and environments.
Classification and Structure:
Kingdom: Bacteria
Phylum: Firmicutes
Class: Clostridia
Order: Clostridiales
Family: Acidaminococcaceae
Genus:Dialister
Species:D. invisus
Dialister invisus is a tiny coccobacillus, a term that describes its unique shape that falls between a sphere (coccus) and a rod (bacillus). Although the precise measurements are not specified, coccobacilli are normally less than 1 micrometer in diameter and length.
This bacterium can exist in various formations – individually, in pairs, in chains, or small clusters.
Dialister invisus is non-motile, indicating it lacks any appendages that enable movement. It is classified as gram-negative due to its thin peptidoglycan layer enveloped by an outer membrane. This bacterium is an obligate anaerobe, which means it cannot survive in oxygen-rich environments.
Dialister invisus is asaccharolytic, implying it does not utilize sugars as an energy source. It generates acetate and propionate as the end products of its metabolism.The bacterium possesses a single chromosome with a genome size of 1.9 Mb. No plasmids have been detected from the partial genome construction.
Dialister invisus exhibits several distinctive characteristics that influence its role within the oral microbiome. This bacterium is known for its ability to produce acetate and propionate from amino acids. This metabolic process can lead to a decrease in pH, resulting in an acidic environment. Such acidity can have implications for the oral ecosystem, affecting microbial interactions and health.
Notably, Dialister invisus expresses antibiotic resistance genes, including ermF, tetQ, and tetW, which confer resistance to macrolides, tetracyclines, and other antibiotics. This resistance highlights the adaptability of this bacterium and underscores the importance of prudent antibiotic usage in clinical settings.
Additionally, D. invisus can form biofilms in conjunction with other oral bacteria like Porphyromonas gingivalis and Treponema denticola. These biofilms enhance adherence and persistence within the oral cavity, playing a role in oral health and disease progression. Moreover, Dialister invisus secretes proteases and hyaluronidases, enzymes that can degrade the extracellular matrix and host tissues, facilitating its invasion and dissemination within the host.
The various strains of Dialister invisus, including CCUG 47026T, CIP108215T, E7.25T, DSM 15470T, and JCM 17566T, collectively exemplify the diversity within this bacterial species and its intricate adaptations and interactions in the oral environment.
Dialister invisus, an asaccharolytic and obligate anaerobe bacterium, can exist symptomatically and asymptomatically within the human body. Its presence and impact largely depend on its location within the body. For instance, when present in the intestinal tract, it does not appear to cause disease. However, when detected, it was associated in urinary tract infections.
The oral cavity is often associated with various oral diseases, such as caries, halitosis, periocoronitis, apical & marginal periodontitis, and endodontic infections. Specifically, its presence in root canals has been shown to the form apical periodontitis lesions.
The bacterium prefers third molar sites in juvenile patients, which can harbor these pathogens even in healthy mouths. This is evidenced by the fact that D. invisus is found in greater incidence in erupted third molars than in plaque from other teeth. Interestingly, the microbial variations in the oral cavity that signal the onset of periodontitis often first appear in the third molar region of teenagers.
Beyond the oral cavity, D. invisus isolated from the female reproductive system has been implicated in bacterial salpingitis & vaginosis. As research into D. invisus continues, it is emerging as a potential endodontic pathogen. However, this species’ actual prevalence and locations may be significantly underrepresented due to the difficulty in isolating and culturing it. It may be present in other body areas that have not yet been discovered.
Studies into the antibiotic resistance of D. invisus have shown that all Dialister strains are resistant to vancomycin but sensitive to colistin and kanamycin. As the association of this bacterium becomes more pronounced with oral disease, the importance of monitoring the evolution of its antibiotic resistance increases. It is crucial in managing its pathogenesis and developing effective treatment strategies.
Understanding the human host’s defense mechanisms against Dialister invisus is essential, especially in inflammatory bowel disease (IBD) and gut dysbiosis.
Mucosal Barrier Integrity: The first line of defense against Dialister invisus and other gut bacteria is the intestinal mucosal barrier. This barrier comprises a layer of mucus and epithelial cells that physically separate the bacteria from the underlying tissues. A healthy mucosal barrier helps prevent the invasion of bacteria, including Dialister invisus, into the gut lining.
Beneficial Microbiota: One of the host’s natural defenses is a diverse and balanced gut microbiota. When the gut is populated with a wide variety of beneficial bacteria, they can compete with potential pathogens like Dialister invisus for resources and space, limiting their growth and impact.
Immune System Surveillance: The host’s immune system detects and acts against invasive bacteria like Dialister invisus. Immune cells in the gut, such as dendritic cells and macrophages, are responsible for monitoring the gut environment and initiating immune responses when necessary.
Secretory Immunoglobulin A (sIgA): sIgA is an antibody found in the gut’s mucosal lining. It plays a crucial role in immune defense against bacteria, including Dialister invisus, by binding them and preventing their adhesion to the gut epithelium. This action limits the ability of the bacteria to colonize and cause harm.
Inflammatory Responses: During an increased load of Dialister invisus, the host’s immune system can mount an inflammatory response. This response includes the release of pro-inflammatory cytokines and launching immune cells to the infection site, helping to contain and eliminate the bacteria.
Microbiota-Metabolite Interactions: Butyrate and other short-chain fatty acids (SCFAs) produced by the gut microbiota play a critical role in maintaining gut health. Butyrate, in particular, has anti-inflammatory properties and can trigger the development of regulatory T cells (Tregs), which help in immune regulation and maintaining gut homeostasis. Dialister invisus and other bacteria contributing to SCFA production indirectly support the host’s immune system.
Adaptive Immunity: Over time, the host’s adaptive immune system can develop specific responses to Dialister invisus if it becomes a recurrent threat. This involves the production of antibodies and memory immune cells that can recognize and respond more effectively to future exposures.
Dialister invisus is predominantly found in the oral cavity of individuals suffering from endodontic infections. The term ‘endodontic’ pertains to the dental pulp, which is the central part of the tooth composed of living connective tissue and cells. While endodontic infections often occur in the root canal, this is not always true.
In humans, the presence of Dialister invisus can lead to several clinical symptoms, including:
Periodontitis: It is an infection and inflammation of the gums & the structures that support the teeth.
Caries: This condition involves the decay and damage of the tooth’s enamel and dentin, which can result in cavities.
Halitosis: Commonly called bad breath, this condition is caused by the accumulation of bacteria and the breakdown of organic compounds in the mouth.
Apical Periodontitis: This is an infection and inflammation of the tissues surrounding the root tip of a tooth. It often occurs as a result of an untreated endodontic infection.
Dialister invisus has implications beyond the oral cavity, with links to systemic diseases such as Crohn’s disease, spondyloarthritis, systemic lupus erythematosus, and autism spectrum disorders. These diseases are intricately tied to alterations in the gut microbiome, which is influenced by D. invisus infection.
Notably, the abundance of D. invisus has been found to vary in patients with different conditions; it is reduced in individuals with Crohn’s disease, while it exhibits a positive association with spondyloarthritis.
Diagnosing Dialister infections typically requires a combination of culture-based & culture-independent methods due to the bacterium’s unique characteristics. It isn’t easy to grow in the laboratory, so culture-independent methods are usually preferred for diagnosis. Here are some diagnostic approaches:
Culture Test:Dialister invisus can be cultured using selective media, such as Columbia blood agar. This medium contains sheep blood, hemin, vitamin K and supports the growth. However, culturing Dialister invisus necessitates specific conditions, primarily anaerobic environments, and extended incubation periods (usually around 7 days at 37°C). Colonies of D. invisus on Columbia blood agar are typically small, circular, and transparent.
Gram Staining: A fundamental technique in microbiology can confirm the identity of D. invisus after culturing or molecular detection methods. This staining technique differentiates bacteria based on the structure of their cell wall. D. invisus possesses a thin peptidoglycan layer encircled by an outer membrane, resulting in a pink or red coloration in gram staining.
Molecular Techniques – 16S rRNA Sequencing: Culture-independent methods are often preferred for diagnosing D. invisus infections since it can be challenging to grow this bacterium in the laboratory. One such method is 16S rRNA sequencing, a molecular technique that identifies bacterial species based on their genetic signatures. This method has been used effectively to detect and isolate D. invisus from various clinical samples.
Fluorescence In Situ Hybridization (FISH): FISH employs fluorescent probes to target and visualize Dialister invisus DNA or RNA in clinical samples.
Checkerboard DNA-DNA hybridization: It is a versatile method in microbiological research, particularly for assessing the presence and quantity of Dialister invisus in complex samples such as subgingival plaque. This technique utilizes DNA probes designed to complement distinct regions of DNA from various bacterial species.
By hybridizing these probes with DNA extracted from a sample, researchers can pinpoint the presence and quantify the abundance of Dialister invisus and other periodontal pathogens. This approach has proven valuable in evaluating the impact of treatments like scaling and root planing on the subgingival microbiota.
Maintaining good oral hygiene is mandatory in preventing oral infections, including those potentially related to bacteria like Dialister invisus. This involves regular brushing and flossing to remove plaque and debris, using mouthwash to kill harmful bacteria, and scheduling routine dental check-ups to catch and address any oral health issues early.
Diet is crucial in oral health maintenance. Avoiding or limiting consuming foods rich in sugars, starches, and acidic substances can help prevent bacterial growth and tooth decay.
If there are signs of infection or inflammation in the teeth or gums, following prescribed antibiotics as directed by a healthcare professional is essential. Timely treatment is critical in preventing the spread of infection.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
